← back to search

Lukas Käsmann

German Cancer Research Center · DE
🔎 Find collaborators in Pulmonary and Respiratory Medicine · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, and Lung Cancer Research Studies.
h-index
21
citations
1,607
works
200
NIH funding
primary concept
email

Recent publications

Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patients
npj Precision Oncology 2026cited by 1position: middledoi
Real-world insights into moderately hypofractionated thoracic radiotherapy in elderly and multimorbid patients with stage II/III NSCLC: a retrospective study
Acta Oncologica 2025cited by 2position: middledoi
Abscopal effects in patients with malignant melanoma treated with radiotherapy and immune checkpoint inhibition: analysis of a large observational multicenter study
Journal for ImmunoTherapy of Cancer 2025cited by 2position: middledoi
Assessing ChatGPT’s Educational Potential in Lung Cancer Radiotherapy From Clinician and Patient Perspectives: Content Quality and Readability Analysis
JMIR Cancer 2025cited by 1position: middledoi
Impact of comorbidities on treatment management and prognosis in patients with anaplastic thyroid cancer (ATC)
Journal of Cancer Research and Clinical Oncology 2025cited by 1position: lastdoi
Empiric stereotactic body radiotherapy for presumed early-stage lung cancer
Strahlentherapie und Onkologie 2025cited by 1position: middledoi
Patient-Relevant Costs for Organ Preservation versus Radical Resection in Locally Advanced Rectal Cancer
Cancers 2024cited by 6position: middledoi
Tumor board simulation improves interdisciplinary decision-making in medical students
Journal of Cancer Research and Clinical Oncology 2024cited by 2position: middledoi
Prognostic significance of pretreatment PET parameters in inoperable, node-positive NSCLC patients with poor prognostic factors undergoing hypofractionated radiotherapy: a single-institution retrospective study
EJNMMI Reports 2024cited by 2position: middledoi
Validation of two predictive models for survival in anaplastic thyroid cancer (ATC)
BMC Cancer 2024cited by 2position: firstdoi
Dosimetric Predictors of Acute Radiation Pneumonitis and Esophagitis in Hypofractionated Thoracic Irradiation of Non-Small Cell Lung Cancer Patients With Poor Prognostic Factors
Advances in Radiation Oncology 2024cited by 1position: middledoi
Langzeitergebnisse der IMRT vs. 3D-konformalen Radiotherapie beim lokal fortgeschrittenem, inoperablem nicht-kleinzelligem Lungenkarzinom (NSCLC)
Strahlentherapie und Onkologie 2024cited by 1position: lastdoi
Psychosocial distress in cancer patients undergoing radiotherapy: a prospective national cohort of 1042 patients in Germany
Journal of Cancer Research and Clinical Oncology 2023cited by 29position: middledoi
Satisfaction with radiotherapy care among cancer patients treated in Germany—secondary analysis of a large multicenter study
Strahlentherapie und Onkologie 2023cited by 10position: middledoi
Current situation in radiation oncology residency—Results of a national survey performed by the working group Young DEGRO of the German Society of Radiation Oncology
Strahlentherapie und Onkologie 2023cited by 7position: middledoi
Successful implementation of online educational lectures of the German Society for Radiation Oncology (DEGRO)
Strahlentherapie und Onkologie 2023cited by 2position: middledoi
International consensus on radiotherapy in metastatic non-small cell lung cancer
Translational Lung Cancer Research 2022cited by 34position: middledoi
Erstmalige interdisziplinäre DKK-Programmplanung durch Zusammenschluss onkologischer Nachwuchsgruppen
Forum 2022cited by 10position: middledoi
Radiation-Induced Lung Injury: Prevention, Diagnostics and Therapy in the Era of the COVID-19 Pandemic
Journal of Clinical Medicine 2022cited by 3position: firstdoi
Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab
BMC Cancer 2022cited by 3position: middledoi
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC—current state and future directions
European Journal of Nuclear Medicine and Molecular Imaging 2021cited by 57position: middledoi
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
Investigational New Drugs 2021cited by 42position: middledoi
Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer—results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group
Strahlentherapie und Onkologie 2021cited by 17position: middledoi
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition
Investigational New Drugs 2021cited by 11position: middledoi
Correction to: Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer—results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group
Strahlentherapie und Onkologie 2021cited by 2position: middledoi
Combination of pembrolizumab with radiotherapy can change treatment paradigm in metastatic “non‐driver” non‐small‐cell lung cancer: Assembling a path
The Clinical Respiratory Journal 2021cited by 1position: lastdoi
Radiation-induced lung toxicity – cellular and molecular mechanisms of pathogenesis, management, and literature review
Radiation Oncology 2020cited by 232position: firstdoi
Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
Radiation Oncology 2020cited by 40position: middledoi
Prognostic factors and outcome of reirradiation for locally recurrent small cell lung cancer—a multicenter study
Translational Lung Cancer Research 2020cited by 8position: firstdoi
Clinical Outcome and Toxicity in the Treatment of Anaplastic Thyroid Cancer in Elderly Patients
Journal of Clinical Medicine 2020cited by 6position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Claus Belka · Cancer Research Center17 papers (2020–2025)Chukwuka Eze · German Center for Lung Research15 papers (2020–2025)Farkhad Manapov · LMU Klinikum14 papers (2020–2025)Julian Taugner · University of Tübingen9 papers (2020–2024)Nina-Sophie Schmidt-Hegemann · LMU Klinikum6 papers (2021–2025)Amanda Tufman · München Klinik6 papers (2020–2025) · 5 papers (2022–2025)Sina Mansoorian · Friedrich-Alexander-Universität Erlangen-Nürnberg5 papers (2024–2025)Niels Reinmuth · Asklepios Fachkliniken München-Gauting5 papers (2021–2025)Maike Trommer · University Hospital Heidelberg4 papers (2023–2025)Thomas Duell · Ludwig-Maximilians-Universität München4 papers (2021–2025)Julian Guggenberger · LMU Klinikum4 papers (2021–2024)Nils Hendrik Nicolay · University Hospital Leipzig4 papers (2023–2025) · 4 papers (2023–2025)Daniel F. Fleischmann · German Cancer Research Center4 papers (2022–2024)Diego Kauffmann‐Guerrero · German Center for Lung Research4 papers (2024–2025)Alexander Fabian · University of Toronto3 papers (2023–2024) · 3 papers (2023–2024)Alexander Nieto · Ludwig-Maximilians-Universität München3 papers (2022–2024)Teresa Augustin · LMU Klinikum3 papers (2020–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pulmonary and Respiratory Medicine · Oncology →